Name:
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)
Type:
Stimulant
AKA:
N/A
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) image
Synthetic substance, no natural derivative
IUPAC Logo
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) image
Zipeprol, a cough suppressant, was developed in the 1960s. It was used for treating cough and respiratory conditions. Its history reflects its role in cough management and its eventual decline in use due to newer treatments. Zipeprol's development highlights advancements in cough suppressant medications and changing treatment practices.
Synthetic Substances Image
Zipeprol is a cough suppressant with central nervous system depressant effects. It causes sedation, reduced heart rate, and constricted pupils. Short-term use is effective for cough relief, but long-term use may lead to dependence and cognitive impairment. Overdose risks include severe sedation, respiratory depression, and potential death. Safe use involves following prescribed doses. Recent research highlights its effectiveness in cough suppression and associated risks.
N/A
Zipeprol, a stimulant and antitussive agent, affects norepinephrine systems, leading to increased alertness and mood enhancement. Immediate effects include mood elevation and increased energy, lasting several hours. Long-term use may result in cognitive impairments and mood disturbances. Research highlights its stimulant effects and risks of psychological dependence.
N/A
Zipeprol, a synthetic compound with anti-tussive properties, was developed in the late 20th century. Its cultural significance involves its use in treating coughs and related conditions. Proponents highlight its effectiveness in cough relief, while opponents raise concerns about its safety and potential for misuse. Its use is primarily medicinal, reflecting ongoing interest in effective cough treatments.
N/A